Regeneron Pharmaceuticals, Inc.
REGN
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$16.90B
▲ +1.0% YoY
Net Income (TTM)
$4.82B
▲ +2.1% YoY
Op. Margin
28.79%
▼ -3.2pp YoY
ROIC
11.50%
▼ -3.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$3.83B
▲ +11.3% YoY
Op. Cash Flow (TTM)
$4.85B
▲ +12.6% YoY
Net Debt
-$6.59B
Net Cash Position
Cash & Equiv.
$9.30B
5Y CAGR: +11.0%
5Y CAGR: +15.3%
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with REGN
Held by ETFs
REGN is in 366 US ETFs. The largest of them, with REGN's weight in each:
Regeneron Pharmaceuticals (REGN) in four numbers
Questions about Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals (REGN) overvalued?
At $916.06, Regeneron Pharmaceuticals' price is 73% above the $530.17 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 20.22 times earnings and 25.28 times free cash flow. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.
What is Regeneron Pharmaceuticals' fair value?
Intrinsiqq's calculator puts Regeneron Pharmaceuticals' fair value at $530.17 a share. It grows earnings per share 1.2% a year for 5 years, applies an exit P/E of 19.7, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $397.63. Every input can be changed on the Intrinsic Value tab.
Is Regeneron Pharmaceuticals a high-quality business?
Regeneron Pharmaceuticals scores 54 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 8 checks computed from SEC filings. Its best check is share count change at -7.0%, and its weakest is margin trend at -10.1pp. The Quality tab shows every check against its target.
Does Regeneron Pharmaceuticals (REGN) pay a dividend, and how much?
Yes. Regeneron Pharmaceuticals (REGN) pays a dividend: $3.59 per share over the last twelve months, a dividend yield of 0.40% at the latest close. The payout takes about 8.0% of earnings. The Dividends tab has the full payment history and the safety score.
Source: 10-Q filed 30 Oct 2026 (period ending 30 Sept 2026), SEC. Price: last close 10 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in REGN's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing REGN
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.